IL ‐10‐modulated dendritic cells from birch pollen‐ and hazelnut‐allergic patients facilitate Treg‐mediated allergen‐specific and cross‐reactive tolerance
Allergy · 2024
DOI: 10.1111/all.16255 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergy, 2024. Verfasst von Patricia Vanessa Heinl und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Division for Experimental and Translational Research, University Medical Center of the Johannes Gutenberg-University, Main…. Hauptthemen laut MEDLINE: Dendritic Cells, T-Lymphocytes, Regulatory, Interleukin-10, Cross Reactions. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Approximately 70% of individuals allergic to birch pollen (Bet v 1.01 [Bet]) develop a secondary food allergy (e.g., hazelnut: Cor a 1.04 [Cor]), due to allergen cross‐reactivity. However, standard immunotherapy for type I allergies often does not improve the food allergy sufficiently. We analyzed the allergen‐specific and cross‐reactive suppressive capacity of primary human regulatory T cells (Treg) induced by autologous IL‐10‐modulated dendritic cells (IL‐10 DC) in vitro and in vivo.
Methods
CD4 + T cells of patients with birch pollen and associated hazelnut allergies were differentiated into Bet‐specific or non‐specific induced Treg (iTreg). After Bet‐ or Cor‐specific restimulation the phenotype, proliferation, and suppressive capacity of iTreg subsets were analyzed. iTreg function was further investigated in humanized mouse models of airway and intestinal allergy, generated by engraftment of peripheral blood mononuclear cells from allergic donors into immunodeficient animals.
Results
After IL‐10 DC priming and allergen‐specific restimulation (Bet or Cor), non‐specific control iTreg remained anergic, whereas Bet‐specific iTreg proliferated extensively and exhibited a regulatory phenotype (enhanced expression of CTLA‐4, PD‐1, TNFR2, IL‐10). Accordingly, activated Bet‐specific iTreg displayed a high capacity to suppress Bet‐ and Cor‐induced responder Th2 cell responses in vitro, indicating induction of both allergen‐specific (birch) and cross‐reactive tolerance (hazelnut). In vivo, the beneficial effect of Bet‐specific iTreg was verified in humanized mouse models of allergic airway and intestinal inflammation, resulting in reduced allergen‐induced clinical symptoms, and immune responses.
Conclusion
Human IL‐10 DC‐induced iTreg facilitate allergen‐specific and cross‐reactive tolerance. Therefore, they are potential candidates for regulatory cell therapy in allergic and autoimmune diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Division for Experimental and Translational Research, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
- Department of Internal Medicine, University Hospital Erlangen, University Erlangen-Nürnberg, Erlangen, Germany.
- Molecular Allergology, Paul-Ehrlich-Institute, Langen, Germany.
- Department of Dermatology, University Medical Center of the Johannes, Gutenberg-University, Mainz, Germany.
- Department of Dermatology, University Hospital Münster, University of Münster, Münster, Germany.
ORCID-Profile: Patricia Vanessa Heinl, Andrea Wangorsch, Iris Bellinghausen, Rahul Khatri
Zitieren
APA
Heinl, P. V., Graulich, E., Weigmann, B., Wangorsch, A., Ose, R., Bellinghausen, I., Khatri, R., Raker, V. K., Scheurer, S., Vieths, S., Saloga, J., & Steinbrink, K. (2024). IL ‐10‐modulated dendritic cells from birch pollen‐ and hazelnut‐allergic patients facilitate Treg‐mediated allergen‐specific and cross‐reactive tolerance. Allergy. https://doi.org/10.1111/all.16255
Vancouver
Heinl PV, Graulich E, Weigmann B, Wangorsch A, Ose R, Bellinghausen I, et al. IL ‐10‐modulated dendritic cells from birch pollen‐ and hazelnut‐allergic patients facilitate Treg‐mediated allergen‐specific and cross‐reactive tolerance. Allergy. 2024. doi:10.1111/all.16255
BibTeX
@article{Heinl2024,
author = {Heinl, Patricia Vanessa and Graulich, Edith and Weigmann, Benno and Wangorsch, Andrea and Ose, Robert and Bellinghausen, Iris and Khatri, Rahul and Raker, Verena K and Scheurer, Stephan and Vieths, Stefan and Saloga, Joachim and Steinbrink, Kerstin},
title = {IL ‐10‐modulated dendritic cells from birch pollen‐ and hazelnut‐allergic patients facilitate Treg‐mediated allergen‐specific and cross‐reactive tolerance},
journal = {Allergy},
year = {2024},
doi = {10.1111/all.16255}
}
EUVIMED